                               SEQUENCE LISTING

<110> CARIS SCIENCE, INC.
 
<120> COMPOSITIONS AND METHODS FOR APTAMER SCREENING

<130> 37901-815.601

<140> PCT/US2013/076611
<141> 2013-12-19

<150> 61/739,558
<151> 2012-12-19

<160> 12    

<170> PatentIn version 3.5

<210> 1
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
atccagagtg acgcagca                                                     18


<210> 2
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
actaagccac cgtgtcca                                                     18


<210> 3
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer


<220>
<223> 5'biotin

<400> 3
atccagagtg acgcagca                                                     18


<210> 4
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer


<220>
<223> 5'biotin

<400> 4
actaagccac cgtgtcca                                                     18


<210> 5
<211> 56
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (19)..(38)
<223> a, c, t, g, unknown or other

<400> 5
atccagagtg acgcagcann nnnnnnnnnn nnnnnnnntg gacacggtgg cttagt           56


<210> 6
<211> 61
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (19)..(43)
<223> a, c, t, g, unknown or other

<400> 6
atccagagtg acgcagcann nnnnnnnnnn nnnnnnnnnn nnntggacac ggtggcttag       60

t                                                                       61


<210> 7
<211> 66
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (19)..(48)
<223> a, c, t, g, unknown or other

<400> 7
atccagagtg acgcagcann nnnnnnnnnn nnnnnnnnnn nnnnnnnntg gacacggtgg       60

cttagt                                                                  66


<210> 8
<211> 71
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (19)..(53)
<223> a, c, t, g, unknown or other

<400> 8
atccagagtg acgcagcann nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnntggacac       60

ggtggcttag t                                                            71


<210> 9
<211> 76
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (19)..(58)
<223> a, c, t, g, unknown or other

<400> 9
atccagagtg acgcagcann nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnntg       60

gacacggtgg cttagt                                                       76


<210> 10
<211> 32
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
ccccccgaat cacatgactt gggcgggggt cg                                     32


<210> 11
<211> 80
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
gggaggacga ugcgguaccg ccucaucauc ggacacgacg uguaucaguu ggcugcagac       60

gacucgcuga ggauccgaga                                                   80


<210> 12
<211> 80
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
gggaggacga ugcggccgcc ucgaacacug acgucgugga accuucgauu gcuagcagac       60

gacucgcuga ggauccgaga                                                   80


